These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3863217)

  • 61. In vitro activity of temocillin, moxalactam and cefotaxime against gram negative bacteria sensitive or resistant to ureidopenicillins and/or cefacedone.
    Bartmann K; Tarbuc R
    Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Dec; 256(2):202-10. PubMed ID: 6324518
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mezlocillin, ceftizoxime, and amikacin alone and in combination against six Enterobacteriaceae in a neutropenic site in rabbits.
    Gerding DN; Peterson LR; Moody JA; Fasching CE
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():207-19. PubMed ID: 3856563
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Overproduced beta-lactamase and the outer-membrane barrier as resistance factors in Serratia marcescens highly resistant to beta-lactamase-stable beta-lactam antibiotics.
    Hechler U; van den Weghe M; Martin HH; Frère JM
    J Gen Microbiol; 1989 May; 135(5):1275-90. PubMed ID: 2695600
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Outer membrane permeability of imipenem in comparison with other beta-lactam antibiotics.
    Hashizume T; Yamaguchi A; Sawai T
    J Antibiot (Tokyo); 1986 Jan; 39(1):153-6. PubMed ID: 3512504
    [No Abstract]   [Full Text] [Related]  

  • 65. In vitro antibacterial activity and beta-lactamase stability of CL 118523, an aminothiazolyl iminomethoxy cephalosporin.
    Chin NX; Neu HC
    Chemioterapia; 1987 Oct; 6(5):329-36. PubMed ID: 3322588
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In vitro susceptibility of recent antibiotic-resistant urinary pathogens to ertapenem and 12 other antibiotics.
    Alhambra A; Cuadros JA; Cacho J; Gómez-Garcés JL; Alós JI
    J Antimicrob Chemother; 2004 Jun; 53(6):1090-4. PubMed ID: 15117925
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.
    Wang FD; Lin ML; Lee WS; Liu CY
    Int J Antimicrob Agents; 2004 Jun; 23(6):590-5. PubMed ID: 15194130
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.
    Jarlier V; Nicolas MH; Fournier G; Philippon A
    Rev Infect Dis; 1988; 10(4):867-78. PubMed ID: 3263690
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
    Medeiros AA; Hare R; Papa E; Adam C; Miller GH
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():119-32. PubMed ID: 3875602
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Emergence of resistance to imipenem in Enterobacter isolates masquerading as Klebsiella pneumoniae during therapy with imipenem/cilastatin.
    Ehrhardt AF; Sanders CC; Thomson KS; Watanakunakorn C; Trujillano-Martin I
    Clin Infect Dis; 1993 Jul; 17(1):120-2. PubMed ID: 8353231
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparative activity of seven extended-spectrum cephalosporins against gram-negative bacilli from blood cultures.
    Norris SM; Guenthner SH; Wenzel RP
    J Antimicrob Chemother; 1985 Aug; 16(2):183-8. PubMed ID: 3934124
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In-vitro susceptibility of 1982 respiratory tract pathogens and 1921 urinary tract pathogens against 19 antimicrobial agents: a Canadian multicentre study. Canadian Antimicrobial Study Group.
    Blondeau JM; Yaschuk Y; Suter M; Vaughan D
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():3-23. PubMed ID: 10225567
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Sch 34343 activity against streptococci and beta-lactam-resistant Enterobacteriaceae.
    Gutmann L; Kitzis MD; Acar JF
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():147-54. PubMed ID: 3897168
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In-vitro studies with ceftazidime.
    Giamarellou H; Avlami A; Matsakas V; Kosmidis J; Daikos GK
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():73-7. PubMed ID: 19802972
    [TBL] [Abstract][Full Text] [Related]  

  • 75. In-vitro activity of cefotetan and other cephalosporins against multiresistant strains of Enterobacteriaceae.
    Leigh DA; Marriner J
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():103-5. PubMed ID: 6573310
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Correlation of predicted serum bactericidal activities and values measured in volunteers.
    Drusano G; Standiford H; Ryan P; McNamee W; Tatem B; Schimpff S
    Eur J Clin Microbiol; 1986 Feb; 5(1):88-92. PubMed ID: 3084247
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Morganella morganii: a newly reported, rare cause of neonatal sepsis.
    Salen PN; Eppes S
    Acad Emerg Med; 1997 Jul; 4(7):711-4. PubMed ID: 9223696
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Integration of selected pharmacologic and microbiologic properties of three new beta-lactam antibiotics: a hypothesis for rational comparison.
    Drusano GL; Ryan PA; Standiford HC; Moody MR; Schimpff SC
    Rev Infect Dis; 1984; 6(3):357-63. PubMed ID: 6330835
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Population analysis of susceptibility to cefotaxime in Enterobacteriaceae.
    Søgaard P
    Acta Pathol Microbiol Immunol Scand B; 1985 Oct; 93(5):365-9. PubMed ID: 4083013
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lack of interference of five new beta-lactam antibiotics with serum creatinine determination.
    LeBel M; Paone RP; Lewis GP
    Drug Intell Clin Pharm; 1983 Dec; 17(12):908-10. PubMed ID: 6317326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.